Half-year report · Q2
8095.TEDINET S100WCCI
Period2024-12-01 → 2025-05-31
Filed2025-07-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥58.0bn | 2023-12-01 → 2024-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥28.1bn | 2023-12-01 → 2024-05-31 | Cons. | Net sales |
| Operating income | ¥2.2bn | 2024-12-01 → 2025-05-31 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2023-12-01 → 2024-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2024-12-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2023-12-01 → 2024-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2024-12-01 → 2025-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2023-12-01 → 2024-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥704m | 2023-12-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss |
| Net income | ¥701m | 2023-12-01 → 2024-05-31 | Cons. | Profit loss |
| Total assets | ¥65.5bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥64.6bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥66.5bn | at 2024-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.5bn | at 2025-05-31 | Cons. | Liabilities |
| Total liabilities | ¥39.3bn | at 2024-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.0bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥29.1bn | at 2024-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.3bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.2bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-11-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.8bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.6bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.9bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥775m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥31.97 | 2024-12-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-63.18 | 2023-12-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.75 | 2023-12-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 39.5% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-05-31 | ¥25m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-05-31 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-05-31 | −¥202m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-05-31 | ¥139m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥11.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥11.6bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥319m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥871m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥8.1bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥8.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥48m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥544m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥1m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥190m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥6.2bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥6.0bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥152m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥679m |
| —segment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| —segment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥521m |
| —segment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥529m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-12-01 → 2024-05-31 | ¥26m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-12-01 → 2024-05-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-12-01 → 2024-05-31 | −¥51m |
| Reconciling Itemsreconciling | revenue | 2023-12-01 → 2024-05-31 | −¥739m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-12-01 → 2024-05-31 | −¥739m |
| Reconciling Itemsreconciling | segment profit | 2023-12-01 → 2024-05-31 | ¥30m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥10.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥10.4bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥495m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥0 |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥6.8bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥6.7bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥60m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥198m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥35m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥551m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥5.4bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥140m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥616m |
| —segment total | revenue | 2023-12-01 → 2024-05-31 | ¥28.8bn |
| —segment total | revenue external | 2023-12-01 → 2024-05-31 | ¥28.1bn |
| —segment total | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥731m |
| —segment total | segment profit | 2023-12-01 → 2024-05-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-05-31 | ¥28.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-05-31 | ¥28.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥739m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-05-31 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 615
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ioa | CurrentQuarterInstant | 832000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -23000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -23000000 | JPY |
| Investments and other assets | Prior1YearInstant | 6639000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 5876000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 25453000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 24833000000 | JPY |
| Deferred organization expenses da | Prior1YearInstant | 0 | JPY |
| Deferred organization expenses da | CurrentQuarterInstant | 0 | JPY |
| Deferred assets | Prior1YearInstant | 0 | JPY |
| Deferred assets | CurrentQuarterInstant | 0 | JPY |
| Assets | Prior1YearInstant | 64595000000 | JPY |
| Assets | CurrentQuarterInstant | 65536000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 9272000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 9087000000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 4365000000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 4678000000 | JPY |
| Short term loans payable | Prior1YearInstant | 11390000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 9076000000 | JPY |
| Accrued expenses | Prior1YearInstant | 3166000000 | JPY |
| Accrued expenses | CurrentQuarterInstant | 3499000000 | JPY |
| Income taxes payable | Prior1YearInstant | 732000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 694000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 684000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 314000000 | JPY |
| Provision for product warranties | Prior1YearInstant | 58000000 | JPY |
| Provision for product warranties | CurrentQuarterInstant | 43000000 | JPY |
| Provision for loss on disaster cl | Prior1YearInstant | 14000000 | JPY |
| Provision for loss on disaster cl | CurrentQuarterInstant | 9000000 | JPY |
| Other cl | Prior1YearInstant | 2218000000 | JPY |
| Other cl | CurrentQuarterInstant | 1788000000 | JPY |
| Current liabilities | Prior1YearInstant | 31903000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 29194000000 | JPY |
| Long term loans payable | Prior1YearInstant | 3445000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 6923000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 909000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 414000000 | JPY |
| Provision for share based payments ncl | Prior1YearInstant | 105000000 | JPY |
| Provision for share based payments ncl | CurrentQuarterInstant | 105000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 2403000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 2363000000 | JPY |
| Other ncl | Prior1YearInstant | 526000000 | JPY |
| Other ncl | CurrentQuarterInstant | 504000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 7389000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 10311000000 | JPY |
| Liabilities | Prior1YearInstant | 39293000000 | JPY |
| Liabilities | CurrentQuarterInstant | 39505000000 | JPY |
| Capital stock | Prior1YearInstant | 4605000000 | JPY |
| Capital stock | CurrentQuarterInstant | 4629000000 | JPY |
| Capital surplus | Prior1YearInstant | 6320000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |